Sponsor
OHSU Knight Cancer Institute
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02070705
This clinical trial studies an imaging technique known as dynamic contrast enhanced magnetic resonance imaging (DCE MRI) in identifying the presence of pancreatic cancer. DCE MRI is a procedure that takes detailed pictures of functional and structural properties inside the body using magnetic field imaging. These images may better characterize pancreatic cancer in patients at high risk or in patients who may have undergone chemotherapy for pancreatic cancer.
Intervention
Ferumoxytol, Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Condition
Familial Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Neoplasm
Investigators
Alexander Guimaraes, Alexander S. Guimaraes